查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1422996

2024-2032 年子宫内膜异位症市场（按类型、诊断和治疗、最终用户和地区）

Endometriosis Market by Type, Diagnosis and Treatment, End Users, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球子宫内膜异位症市场规模达到24亿美元。展望未来， IMARC Group预计到2032年市场规模将达到37亿美元，2024-2032年复合年增长率（CAGR）为4.71%。由于人们对症状和诊断的认识不断提高、各种仿製药的广泛使用、创新治疗方法的发展以及临床试验数量的增加，全球市场正在经历稳定增长。

子宫内膜异位症市场分析：

市场成长与规模：在该病患病率不断上升、意识不断提高以及医疗保健基础设施进步的推动下，全球市场正在经历强劲成长。随着越来越多的人寻求子宫内膜异位症的诊断和治疗，市场规模不断扩大，从而促进了对创新治疗解决方案和全面医疗保健服务的需求。

主要市场驱动因素：主要驱动因素包括人们对女性健康问题的认识不断提高、诊断能力的提高以及研发活动的增加。此外，对以患者为中心的护理的关注和新颖治疗方案的引入对市场成长做出了重大贡献。

技术进步：先进影像技术、微创外科手术和分子诊断等技术进步在塑造治疗格局方面发挥关键作用。这些创新提高了诊断准确性，改善了手术结果，并为个人化治疗方法铺平了道路。

产业应用：该市场涵盖广泛的产业应用，包括製药、医疗器材和医疗保健服务。製药公司正在积极开发药物并将其商业化，而医疗设备製造商则为诊断和外科手术中使用的创新工具和设备做出贡献。

主要市场趋势：主要趋势包括强调早期诊断、加强製药公司和研究机构之间的合作以及将远距医疗整合到患者护理中。此外，向整体和以患者为中心的方法的转变，不仅解决症状，而且解决疾病的情感和心理方面，正在变得越来越突出。

地理趋势：地理趋势揭示了不同地区的市场成长率不同，其中北美由于先进的医疗基础设施而在市场份额方面处于领先地位。在子宫内膜异位症盛行率上升和医疗保健意识提高的推动下，亚太地区正在大幅成长。

竞争格局：竞争格局的特征是主要参与者透过研究、开发和策略伙伴关係积极为市场成长做出贡献。市场动态包括老牌製药公司与将创新推向前沿的新兴企业之间的平衡。

挑战与机会：挑战包括与延迟诊断、某些地区获得医疗保健的机会有限以及需要更有效的长期管理方案相关的问题。机会在于研究的进步、全球合作的加强以及解决市场未满足需求的突破性疗法的潜力。

未来展望：市场前景广阔，预计将持续成长。持续的研究、技术创新和对以患者为中心的护理的关注预计将推动更有效治疗方法的开发，进一步加强子宫内膜异位症的整体管理。随着意识的不断增强，市场即将成长，为老牌企业和新兴企业提供了机会。

子宫内膜异位症市场趋势：

提高认识和诊断率

推动市场成长的主要因素之一是意识的提高和诊断率的提高。近年来，大众对子宫内膜异位症的认识显着提高，子宫内膜异位症是一种类似子宫内膜的组织生长在子宫外的疾病。这种意识的提高导致更多的女性认识并报告症状，从而促进早期诊断和介入。此外，医疗保健专业人员对这种情况的了解越来越多，从而可以做出更准确、更及时的诊断。因此，对有效治疗和管理方案的需求增加，推动了市场的成长。

医学研究和技术的进步

医学研究和技术的不断进步在塑造子宫内膜异位症治疗方案方面发挥了至关重要的作用。创新治疗方法的发展，包括新药物、微创手术技术和个人化治疗计划，显着扩大了患者的选择范围。先进的影像技术和生物标记识别等尖端诊断工具有助于更精确、更有效率的诊断。这些进步不仅可以改善患者的治疗效果，还可以透过为这种疾病创造一系列新颖且更有效的疗法来推动市场成长。

增加女性医疗保健支出和可近性

全球女性人口对女性健康的日益重视和医疗保健支出的增加促进了市场的扩张。随着社会认识到解决妇女健康问题的重要性，人们更愿意分配资源用于与子宫内膜异位症相关的研究、开发和获得优质医疗保健服务。此外，改善医疗保健设施的可近性，特别是在发展中地区，可确保更大比例的女性能够就这种疾病寻求医疗护理并接受适当的治疗。医疗保健支出的增加和可及性的提高相结合，为子宫内膜异位症领域的研究和患者护理创造了更具支持性的环境，从而推动了市场的成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球子宫内膜异位症市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 腹膜表浅病变
    • 市场走向
    • 市场预测
  • 子宫内膜异位症
    • 市场走向
    • 市场预测
  • 深部浸润型子宫内膜异位症
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：透过诊断与治疗

  • 诊断
    • 市场走向
    • 关键环节
      • 超音波
      • 骨盆检查
      • 腹腔镜检查
      • 磁振造影 (MRI)
      • 子宫腔镜检查
      • 子宫超音波造影
    • 市场预测
  • 治疗
    • 市场走向
    • 关键环节
      • 荷尔蒙疗法
      • 疼痛管理
      • 保守手术
    • 市场预测

第 8 章：市场区隔：依最终使用者划分

  • 医院
    • 市场走向
    • 市场预测
  • 居家护理
    • 市场走向
    • 市场预测
  • 专科中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Abbvie Inc.
    • Bayer AG
    • Debiopharm Group
    • Gedeon Richter Plc
    • Kissei Pharmaceutical Co. Ltd.
    • Myovant Sciences GmbH
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A6676

Abstract

The global endometriosis market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. The global market is experiencing steady growth driven by the rising awareness about symptoms and diagnosis, the widespread availability of various generic drugs, the development of innovative therapeutic approaches, and the increasing number of clinical trials.

Endometriosis Market Analysis:

Market Growth and Size: The global market is experiencing robust growth, driven by an increasing prevalence of the condition, rising awareness, and advancements in healthcare infrastructure. The market size continues to expand as more individuals seek diagnosis and treatment for endometriosis, fostering a demand for innovative therapeutic solutions and comprehensive healthcare services.

Major Market Drivers: Key drivers include the growing awareness of women's health issues, improved diagnostic capabilities, and a rise in research and development activities. Additionally, the focus on patient-centric care and the introduction of novel treatment options contribute significantly to the market growth.

Technological Advancements: Technological advancements, such as advanced imaging techniques, minimally invasive surgical procedures, and molecular diagnostics, play a pivotal role in shaping the landscape of treatment. These innovations enhance diagnostic accuracy, improve surgical outcomes, and pave the way for personalized treatment approaches.

Industry Applications: The market encompasses a wide range of industry applications, including pharmaceuticals, medical devices, and healthcare services. Pharmaceutical companies are actively developing and commercializing medications, while medical device manufacturers contribute with innovative tools and equipment used in diagnostic and surgical procedures.

Key Market Trends: Key trends include the emphasis on early diagnosis, increasing collaborations between pharmaceutical companies and research institutions, and the integration of telemedicine in patient care. Additionally, a shift towards holistic and patient-centered approaches, addressing not only symptoms but also the emotional and psychological aspects of the condition, is gaining prominence.

Geographical Trends: Geographical trends reveal varying rates of market growth across regions, with North America leading in terms of market share due to advanced healthcare infrastructure. The Asia Pacific region is witnessing substantial growth, driven by a rising prevalence of endometriosis and increasing healthcare awareness.

Competitive Landscape: The competitive landscape is characterized by key players actively contributing to the market's growth through research, development, and strategic partnerships. The market dynamics include a balance between established pharmaceutical companies and emerging players bringing innovation to the forefront.

Challenges and Opportunities: Challenges encompass issues related to delayed diagnosis, limited accessibility to healthcare in certain regions, and the need for more effective long-term management options. Opportunities lie in advancements in research, increased global collaboration, and the potential for breakthrough therapies addressing unmet needs in the market.

Future Outlook: The future of the market appears promising, with sustained growth anticipated. Continued research, technological innovations, and a focus on patient-centered care are expected to drive the development of more effective treatments, further enhancing the overall management of endometriosis. As awareness continues to grow, the market is poised for growth, presenting opportunities for both established and emerging players.

Endometriosis Market Trends:

Increased awareness and diagnosis rates

One of the primary factors fueling the growth of the market is the heightened awareness and improved diagnosis rates. In recent years, there has been a significant increase in public awareness regarding endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus. This heightened awareness has led to more women recognizing and reporting symptoms, prompting early diagnosis and intervention. Additionally, healthcare professionals are increasingly knowledgeable about the condition, leading to more accurate and timely diagnoses. As a result, the demand for effective treatments and management options has risen, driving growth in the market.

Advancements in medical research and technology

Ongoing advancements in medical research and technology have played a crucial role in shaping the landscape of endometriosis treatment options. The development of innovative therapeutic approaches, including new medications, minimally invasive surgical techniques, and personalized treatment plans, has significantly expanded the available choices for patients. Cutting-edge diagnostic tools, such as advanced imaging techniques and biomarker identification, contribute to more precise and efficient diagnosis. These advancements not only enhance patient outcomes but also drive market growth by creating a robust pipeline of novel and more effective therapies for this medical disorder.

Increasing female healthcare spending and accessibility

The growing emphasis on women's health and increased healthcare spending among the female population globally has contributed to the expansion of the market. As societies recognize the importance of addressing women's health issues, there is a greater willingness to allocate resources for research, development, and access to quality healthcare services related to endometriosis. Moreover, improved accessibility to healthcare facilities, especially in developing regions, ensures that a larger proportion of women can seek medical attention and receive appropriate treatment for this medical disorder. This combination of increased healthcare spending and enhanced accessibility propels market growth by fostering a more supportive environment for both research and patient care in the field of endometriosis.

Endometriosis Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, diagnosis and treatment, and end users.

Breakup by Type:

Superficial Peritoneal Lesion

Endometrioma

Deeply Infiltrating Endometriosis

Others

The report has provided a detailed breakup and analysis of the market based on the type. This includes superficial peritoneal lesion, endometrioma, deeply infiltrating endometriosis, and others.

Superficial peritoneal lesions are a common type of this disorder, characterized by the presence of endometrial-like tissue on the peritoneum-the thin membrane lining the abdominal cavity. These lesions often cause inflammation, scarring, and pain. Despite being superficial, they can significantly impact a patient's quality of life. Treatment approaches for superficial peritoneal lesions may include pain management, hormonal therapies, or surgical interventions to remove or ablate the lesions.

On the other hand, endometriomas, also known as ovarian cysts or chocolate cysts, occur when endometriotic tissue forms a cyst on the ovaries. These cysts can vary in size and may lead to pelvic pain, infertility, or complications during menstruation. Management of endometriomas often involves a combination of medical and surgical interventions. Surgical options may include cystectomy to remove the cyst while preserving ovarian tissue or oophorectomy in more severe cases. Hormonal treatments are also commonly employed to manage symptoms and prevent recurrence.

Furthermore, deeply infiltrating endometriosis involves the penetration of endometrial-like tissue into the deeper layers of organs within the pelvic cavity, such as the bowel, bladder, or uterosacral ligaments. This form can cause severe pain, organ dysfunction, and fertility issues. Management of deeply infiltrating endometriosis often requires specialized surgical procedures, such as excision surgery, to remove the deeply embedded tissue. Multidisciplinary care, involving gynecologists and other specialists, is crucial for comprehensive management. Hormonal therapies may also be employed to control symptoms and prevent recurrence in cases of deeply infiltrating endometriosis.

Breakup by Diagnosis and Treatment:

Diagnosis

Ultrasound

Pelvic Exam

Laparoscopy

Magnetic Resonance Imaging (MRI)

Hysteroscopy

Sonohysterography

Treatment

Hormonal Therapy

Pain Management

Conservative Surgery

A detailed breakup and analysis of the market based on the diagnosis and treatment have also been provided in the report. This includes diagnosis (ultrasound, pelvic exam, laparoscopy, magnetic resonance imaging (MRI), hysteroscopy, and sonohysterography) and treatment (hormonal therapy, pain management, and conservative surgery).

The diagnosis involves a multi-faceted approach, combining clinical evaluation, imaging studies, and, in some cases, surgical procedures. Clinicians rely on a detailed medical history, including the description of symptoms such as pelvic pain, dysmenorrhea, and infertility. Physical examinations, including pelvic exams, may provide additional insights. Imaging techniques, such as transvaginal ultrasound or magnetic resonance imaging (MRI), aid in visualizing endometrial lesions and assessing their extent. Definitive diagnosis often requires laparoscopic surgery, allowing direct visualization and biopsy of endometriotic tissue.

On the other hand, the management of this disorder is tailored to individual patient needs and may involve a combination of medical, surgical, and supportive interventions. Hormonal therapies, including birth control pills, progestins, or GnRH agonists, are commonly employed to control symptoms by suppressing estrogen production. Non-steroidal anti-inflammatory drugs (NSAIDs) may be used for pain relief. In cases where fertility is a concern, assisted reproductive technologies (ART) or fertility-preserving surgeries may be considered. Surgical interventions, such as laparoscopic excision or ablation of endometrial lesions, aim to alleviate symptoms and improve fertility. In severe cases, particularly with deeply infiltrating endometriosis, more extensive surgeries may be necessary, involving excision of affected organs or tissues. Multidisciplinary care, involving gynecologists, fertility specialists, and pain management experts, is crucial for comprehensive treatment.

Breakup by End Users:

Hospitals

Homecare

Speciality Centers

Others

Hospitals represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end users. This includes hospitals, homecare, speciality centers, and others According to the report, hospitals represented the largest segment.

Hospitals serve as critical end-users in the market, playing a central role in diagnosis, treatment, and management of the condition. These institutions provide comprehensive care, including surgical interventions, medication administration, and post-operative monitoring. The collaborative nature of hospital settings facilitates the coordination of multidisciplinary teams, comprising gynecologists, surgeons, and other specialists, ensuring a holistic approach to the medical disi care. Moreover, hospitals often serve as hubs for medical research and innovation, actively contributing to the development of advanced treatment modalities and enhancing the overall landscape of this disorder management.

On the contrary, homecare represents an increasingly important segment in patient care, offering personalized and convenient solutions for individuals managing the chronic nature of the condition. Home-based care involves the administration of medications, pain management strategies, and monitoring of symptoms in the familiar and comfortable environment of patients' homes. This segment has witnessed growth with the advent of telemedicine, allowing healthcare professionals to remotely engage with patients, provide consultations, and monitor treatment adherence. Homecare not only enhances patient comfort but also contributes to cost-effective and efficient healthcare delivery, aligning with the trend toward patient-centric care models in the market.

Moreover, specialty centers dedicated to women's health and gynecological care have emerged as specialized end-users in the market. These centers focus on delivering targeted and specialized services for disorder diagnosis, treatment, and support. With a dedicated focus on gynecological conditions, these centers often house experts in the field, ensuring a high level of expertise and personalized care for patients with endometriosis. The establishment of these centers contributes to streamlined and efficient care pathways, fostering an environment that prioritizes the unique needs of individuals affected by endometriosis. Additionally, specialty centers frequently serve as hubs for clinical trials and research, driving advancements in the understanding and management of this medical disorder.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest endometriosis market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has consistently held a prominent position as the largest market, driven by factors such as advanced healthcare infrastructure, high awareness levels, and a significant focus on women's health. The region benefits from robust research and development activities, leading to the continuous introduction of innovative treatment options. Additionally, increasing awareness campaigns and advocacy efforts contribute to early detection and treatment. The prevalence of endometriosis cases and a well-established healthcare system with access to cutting-edge technologies further solidify North America's dominance in the global market.

The Asia Pacific region is witnessing substantial growth in the market, propelled by a rising prevalence of the condition, improving healthcare infrastructure, and increased awareness. As societies in the region become more attuned to women's health issues, there is a growing emphasis on early diagnosis and effective management of endometriosis. Pharmaceutical companies are expanding their presence in the Asia Pacific, introducing novel therapies and leveraging partnerships to address the changing healthcare needs of the population. Moreover, cultural shifts and changing demographics contribute to a greater focus on women's health in the region, fostering a conducive environment for market expansion.

Europe stands as a significant market, characterized by a high prevalence of the condition and a well-established healthcare system. The region benefits from extensive research initiatives, leading to the development of advanced treatment options. European countries prioritize women's health, and initiatives for early detection and management of endometriosis contribute to market growth. Collaboration between pharmaceutical companies and research institutions enhances the region's capabilities in driving innovations. The European market for endometriosis is characterized by a comprehensive approach to patient care, with a focus on both medical interventions and supportive services.

Latin America is experiencing a growing awareness of the disorder, leading to an expanding market for treatment options. The region grapples with challenges such as limited access to healthcare in certain areas, but initiatives aimed at improving healthcare infrastructure contribute to addressing these issues. Rising advocacy for women's health and increasing efforts to reduce the diagnostic and treatment gap are driving market growth in Latin America. Pharmaceutical companies are exploring opportunities in this region, introducing therapies and collaborating with local healthcare providers to enhance accessibility to endometriosis care.

The Middle East and Africa are emerging markets, marked by a gradual increase in awareness and healthcare infrastructure development. While the prevalence of this disorder is gaining recognition, the region faces challenges related to societal stigmas and limited healthcare resources in certain areas. However, ongoing efforts to address women's health issues and improve healthcare accessibility contribute to the market's growth. Pharmaceutical companies are increasingly exploring partnerships and market entry strategies to tap into the potential of this region, aiming to provide effective solutions for individuals affected by this disorder.

Leading Key Players in the Endometriosis Industry:

The key players in the market are driving growth through strategic initiatives, research and development, and market expansion. Pharmaceutical companies invest heavily in developing and commercializing innovative therapies for endometriosis. These companies leverage their expertise to create advanced medications that address the specific needs of patients, improving treatment outcomes. Collaborations and partnerships with research institutions further enhance their capabilities in understanding the disease and developing breakthrough solutions. Additionally, key players focus on expanding their market presence through geographical expansion and acquisitions. By entering emerging markets and acquiring smaller companies with promising pipelines, these players secure a competitive edge. Furthermore, they engage in educational initiatives and awareness campaigns, aiming to increase understanding of endometriosis among healthcare professionals and the general public, ultimately driving demand for their products and contributing to the overall growth of the market.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

AbbVie Inc.

Bayer AG

Debiopharm Group

Gedeon Richter Plc

Kissei Pharmaceutical Co. Ltd.

Myovant Sciences GmbH

Sanofi S.A.

Teva Pharmaceutical Industries Ltd.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

January 8, 2024: Abbott and Tandem Diabetes Care, Inc. have jointly revealed the t:slim X2 insulin pump, equipped with Control-IQ technology has become the inaugural automated insulin delivery (AID) system to seamlessly integrate with Abbott's recently launched FreeStyle Libre 2 Plus sensor. This sensor represents Abbott's latest advancement in continuous glucose monitoring (CGM) technology, marking a collaborative effort to enhance the capabilities of insulin delivery systems and continuous glucose monitoring for individuals managing diabetes.

January 9, 2024: AbbVie introduced PRODUODOPA (foslevodopa/foscarbidopa) in the European Union. This medication is designed to address advanced Parkinson's disease accompanied by severe motor fluctuations, hyperkinesia (excessive movement), or dyskinesia (involuntary movement). PRODUODOPA is specifically intended for situations where combinations of existing Parkinson's medicinal products have not yielded satisfactory results.

January 8, 2024: Bayer announced the expansion of the clinical development program for the investigational compound elinzanetant.

Key Questions Answered in This Report:

  • How has the global endometriosis market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global endometriosis market?
  • What is the impact of each driver, restraint, and opportunity on the global endometriosis market?
  • What are the key regional markets?
  • Which countries represent the most attractive endometriosis market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the endometriosis market?
  • What is the breakup of the market based on the diagnosis and treatment?
  • Which is the most attractive diagnosis and treatment in the endometriosis market?
  • What is the breakup of the market based on the end users?
  • Which is the most attractive end users in the endometriosis market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global endometriosis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endometriosis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Superficial Peritoneal Lesion
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Endometrioma
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Deeply Infiltrating Endometriosis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Diagnosis & Treatment

  • 7.1 Diagnosis
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Ultrasound
      • 7.1.2.2 Pelvic Exam
      • 7.1.2.3 Laparoscopy
      • 7.1.2.4 Magnetic Resonance Imaging (MRI)
      • 7.1.2.5 Hysteroscopy
      • 7.1.2.6 Sonohysterography
    • 7.1.3 Market Forecast
  • 7.2 Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Hormonal Therapy
      • 7.2.2.2 Pain Management
      • 7.2.2.3 Conservative Surgery
    • 7.2.3 Market Forecast

8 Market Breakup by End Users

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Speciality Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Abbvie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Debiopharm Group
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Gedeon Richter Plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Kissei Pharmaceutical Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Myovant Sciences GmbH
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Sanofi S.A.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

  • Figure 1: Global: Endometriosis Market: Major Drivers and Challenges
  • Figure 2: Global: Endometriosis Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Endometriosis Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Endometriosis Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Endometriosis Market: Breakup by Diagnosis & Treatment (in %), 2023
  • Figure 6: Global: Endometriosis Market: Breakup by End Users (in %), 2023
  • Figure 7: Global: Endometriosis Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Endometriosis (Superficial Peritoneal Lesion) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Endometriosis (Superficial Peritoneal Lesion) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Endometriosis (Endometrioma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Endometriosis (Endometrioma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Endometriosis (Deeply Infiltrating Endometriosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Endometriosis (Deeply Infiltrating Endometriosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Endometriosis (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Endometriosis (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Endometriosis (Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Endometriosis (Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Endometriosis (Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Endometriosis (Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Endometriosis (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Endometriosis (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Endometriosis (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Endometriosis (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Endometriosis (Speciality Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Endometriosis (Speciality Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Endometriosis (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Endometriosis (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Endometriosis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Endometriosis Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Endometriosis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Endometriosis Industry: Drivers, Restraints, and Opportunities
  • Figure 78: Global: Endometriosis Industry: Value Chain Analysis
  • Figure 79: Global: Endometriosis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endometriosis Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Endometriosis Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Endometriosis Market Forecast: Breakup by Diagnosis & Treatment (in Million US$), 2024-2032
  • Table 4: Global: Endometriosis Market Forecast: Breakup by End Users (in Million US$), 2024-2032
  • Table 5: Global: Endometriosis Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Endometriosis Market: Competitive Structure
  • Table 7: Global: Endometriosis Market: Key Players